Nevro announces 63 job cuts amid successful Q4 results
The company announced the cuts just whilst confirming that it’s sales in the indication of Painful Diabetic Neuropathy saw an increase of 29%
12 January 2024
12 January 2024
The company announced the cuts just whilst confirming that it’s sales in the indication of Painful Diabetic Neuropathy saw an increase of 29%
Axon Therapy employs magnetic peripheral nerve stimulation to deliver a non-invasive treatment.
Nexalin is engaging with the FDA to plan clinical trials to investigate the HALO Clarity device as an at-home treatment for a variety of mental health conditions.
The menstrual pad comes designed with a removable strip indicated to help carry out diabetes tests based on blood samples.
AIRS Medical is now permitted to sell SwiftMR across the EU's 27 countries, Turkey, the EEA, Great Britain and Switzerland.
The Electrophysiology division’s assets include the CE-marked CENTAURI System and the QuickShot catheter ablation system.
The approval of VISUMAX 800 comes after the announcement of ZEISS’ $1bn deal with Dutch Ophthalmic Research Center.
The Symani Surgical System is a robotic technology designed specifically for microsurgery and supermicrosurgery.
GlobalData predicts that the major technology themes expected to influence the medical device industry in 2024 are AI, cybersecurity, robotics, AI regulation, and digitalization. Furthermore, remote patient monitoring and precision medicine have been identified as the major industry themes set to shape the the medical devices market in 2024.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Give your business an edge with our leading industry insights.